200 to 300 mill aud market cap would definatley be a transformational leap for zelda - the question is what key fundimentals are required that zelda is yet to produce.
*distribution *clinically validated intellectual property *clearer paths to market *revenue
are we closer then we think?
- Forums
- ASX - By Stock
- ZLD
- Correspondance with management thread
Correspondance with management thread, page-30
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.077M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2166 | 81.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.5¢ | 432 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2128 | 0.810 |
1 | 1250 | 0.805 |
1 | 650 | 0.800 |
1 | 500 | 0.750 |
2 | 6109 | 0.730 |
Price($) | Vol. | No. |
---|---|---|
0.805 | 432 | 1 |
0.860 | 581 | 1 |
0.880 | 355 | 1 |
0.950 | 1000 | 1 |
0.960 | 817 | 1 |
Last trade - 09.56am 16/07/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online